According to Immutep's latest financial reports the company's current earnings (TTM) are -$9.21 M. In 2021 the company made an earning of -$0.03 B a decrease over its 2020 earnings that were of -$9.26 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2021 | -$0.03 B | 142.76% |
2020 | -$9.26 M | -28.16% |
2019 | -$0.02 B | 36.64% |
2018 | -$9.43 M | 21.42% |
2017 | -$7.77 M | -83.55% |
2016 | -$0.05 B | 90.52% |
2015 | -$0.03 B | 97.4% |
2014 | -$0.02 B | -9.17% |
2013 | -$0.02 B | -32.31% |
2012 | -$0.03 B | -9.42% |
2011 | -$0.03 B | 120.35% |
2010 | -$0.02 B | 330.66% |
2009 | -$2.38 M | 31.37% |
2008 | -$1.81 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Illumina ILMN | $0.90 B | -9,900.18% | ๐บ๐ธ USA |
![]() FibroGen FGEN | -$0.29 B | 2,971.65% | ๐บ๐ธ USA |
![]() HTG Molecular Diagnostics
HTGM | -$0.02 B | 92.64% | ๐บ๐ธ USA |